Relatively Speaking
Accelerating Cross-Sector Integration in Pharma and Nutraceuticals
Early-Phase Oncology Trials Shaping the Future of Cancer Research
From the “AI Pilot Graveyard” to Enterprise- Grade Impact
Controlling Polysorbate Degradation
EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
.webp)
KNOWLEDGE BANK
-
Articles
What Is Clinical Pharmacology and Its Importance for Drug Development and Patient Care
Clinical pharmacology is the critical interface between laboratory science and the education of patients Put simply it is the science that researches the interaction of drugs with the human body and the reaction of the latter to drugs People pose the question what is clinical pharmacology The solution can be found in its multidisciplinary character of the matter combining pharmacology medicine ge...
Prescription Drugs and Personalized Medicine: A New Era in Pharma
The field of medicine is rapidly evolving and one of the most exciting advancements is personalized medicine This approach tailors medical treatment to the individual characteristics of each patient
Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus
Paracelsus in the th century established the principle of toxicology that the dose of a medicinal defines the difference between a remedy and a toxic effect
The Role of Technology in Drug Anti-Counterfeiting Efforts
With the rise of drug counterfeiting posing a serious threat to global public health the role of technology in anticounterfeiting efforts has become increasingly vital As counterfeit drugs continue to infiltrate the market
AI-Native R&D: Transforming Drug Discovery Through Intelligent Automation
For four decades pharmaceutical research productivity has moved stubbornly in the wrong direction A new medicine still takes ten to fifteen years to reach patients at a capitalised cost approaching US billion
COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?
It was not uncommon to name the year as annus horribilis as the SARSCoV quickly spread all over the globe causing the first pandemic in years leading to devastating consequences on health economy and the society in general Neither drugs nor vaccines were available for more or less the whole first year of the pandemic causing devastation helplessness and uncertainty Since the beginning of the COV...
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Prescription Drugs and Personalized Medicine: A New Era in Pharma
Kate Williamson
Personalized medicine is revolutionizing healthcare by tailoring treatments to individual genetic, environmental, and lifestyle factors. This approach enhances the effectiveness of prescription drugs,...
-
2
Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus
William M. Pardridge
The development of biologics for the treatment of neural disorders has been slow, because these large molecule drugs do not cross the blood-brain barrier (BBB). Solutions to the BBB drug delivery prob...
-
3
The Role of Technology in Drug Anti-Counterfeiting Efforts
Kate Williamson
The escalating threat of drug counterfeiting demands robust solutions. This article explores the pivotal role of technology, including blockchain, AI, and IoT, in anti-counterfeiting efforts. Serializ...
-
4
AI-Native R&D: Transforming Drug Discovery Through Intelligent Automation
Lakshmi
Artificial intelligence has moved beyond pilot projects into the architecture of pharmaceutical research itself. This article examines the shift from AI-enabled to AI-native R&D, in which closed-l...
-
5
COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?
Kenneth Lundstrom
Although COVID-19 vaccines have proven efficient and safe, the continuous emergence of novel SARS-CoV-2 mutants, properly called variants of concern, has resulted in a race between vaccine efficacy an...
press releases Read more...
Carterra and Grenova Robotics Integrate Carterra Vega™ with KX2 Collaborative Robot to Create Automated HT-SPR Work Cell
Carterra and Grenova Robotics today announced the integration of Carterra Vega highthroughput surface plasmon resonance HTSPR platform with Grenova Robotics KX collaborative robot to create an automated work cell for drug discovery laboratories The integrated system enables researchers
Palisade Bio Announces First Patient Dosed in Global Phase 2b ASCENTRA-UC Study Evaluating Once-Daily Oral PALI-2108 for the Treatment of Ulcerative Colitis
Palisade Bio Inc a clinicalstage biopharmaceutical company developing oral therapies for immunemediated and fibrotic diseases today announced that the first patient has been dosed in ASCENTRAUC its global Phase b clinical trial evaluating PALI in approximately patients with moderately to severely a...
London Biotechnology Show 2026 to Unite Global Life Sciences Leaders, Innovators, Investors
The London Biotechnology Show will return to ExCeL London on November bringing together biotechnology and pharmaceutical companies researchers healthcare professionals investors policymakers and technology providers to explore the breakthroughs and commercial opportunities shaping
Enveda Collaborates with Anthropic to Accelerate Drug Development
Enveda a biotechnology company using AI to translate natures chemistry into new medicines today announced results from its collaboration with Anthropic to streamline critical documentation processes in drug development Working with Claude Enveda developed AIenabled workflows to review Good Manufactu...
Events Read more...
28 - 30
Oct 2026BIOPLUS-INTERPHEX KOREA 2026
COEX, Seoul
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
04 - 05
Nov 2026Advanced Therapies USA
Hynes Convention Center, Bosto...
05 - 05
Nov 2026PDA Contamination Control Strategy Workshop
Sheraton Grand Incheon Hotel,...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
LATEST NEWS Read more...
Strand Therapeutics Doses First Patients with STX-003, a Systemic Programmable mRNA Therapy Designed for Tumor-Selective Activation
Strand Therapeutics a clinicalstage biotechnology company pioneering programmable mRNA therapeutics today announced that the first patients have been dosed in ASCENT the Phase clinical trial of STX STX is an intravenously delivered selfreplicating mRNA therapy designed
Idorsia and SPV investors partner to unlock the blockbuster potential of TRYVIO/JERAYGO with a targeted launch in specialists
Idorsia Ltd announced a proposed commercialization partnership between Idorsia and noteholders in Idorsia Investments SARL SPV designed to unlock the substantial global commercial opportunity of TRYVIO JERAYGO aprocitentan the first and only dual endothelin receptor antagonist approved for systemic
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
Roche announced today the global launch of the VENTANA BAP SP test This automated readytouse immunohistochemistry IHC assay provides a reliable highly specific diagnostic tool to help clinicians and pathologists accurately identify mesothelioma and distinguish it from other malignancies including no...
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Stevanato Group SpA a leading global provider of drug containment drug delivery and diagnostic solutions to the pharmaceutical biotechnology and life sciences industries today announced a collaboration with Aptar Pharma to provide systemlevel data supporting earlier evaluation of prefilled syringe c...
Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Patients With Recurrent Endometrial Cancer
Merck known as MSD outside of the United States and Canada today announced the first presentation of results from the pivotal Phase TroFuse trial evaluating sacituzumab tirumotecan sacTMT an investigational TROPdirected antibodydrug conjugate ADC being developed in collaboration with KelunBiotech i...
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Tempus AI Inc announced that its xR assay has received certification under the European Unions In Vitro Diagnostic Regulation IVDR as a Class C in vitro diagnostic device The certification covers Tempus quality management system for nextgeneration sequencing devices for cancer genomic profiling to s...
